SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-000188
Filing Date
2022-01-04
Accepted
2022-01-04 16:10:49
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form4-01042022_040117.html 4  
1 form4-01042022_040117.xml 4 3719
  Complete submission text file 0001415889-22-000188.txt   5155
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address
Cloyd Mary Ann (Reporting) CIK: 0001666769 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 22505924